Cargando…
Trazodone and patient outcomes in dementia—Limitations of naturalistic cohort data
The unfolded protein response has been increasingly implicated as an important pathological pathway and target for therapeutic intervention in neurodegeneration. The licensed antidepressant trazodone is one drug which has been proposed to act on this pathway and may therefore be a potential therapy....
Autores principales: | Sidhom, Emad, Padilla, Mc Stephen, Lewis, Jonathan, White, Simon, O’Brien, John T., Mallucci, Giovanna R., Underwood, Benjamin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543738/ https://www.ncbi.nlm.nih.gov/pubmed/35921312 http://dx.doi.org/10.1002/gps.5777 |
Ejemplares similares
-
Targeting the Unfolded Protein Response as a Disease-Modifying Pathway in Dementia
por: Sidhom, Emad, et al.
Publicado: (2022) -
TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023) -
Trazodone use and risk of dementia: A population-based cohort study
por: Brauer, Ruth, et al.
Publicado: (2019) -
TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report
por: Siwek, Marcin, et al.
Publicado: (2023) -
Mortality in dementia with Lewy bodies compared with Alzheimer’s dementia: a retrospective naturalistic cohort study
por: Price, Annabel, et al.
Publicado: (2017)